Anges Quebec

Anges Québec is a venture capital firm based in Montreal, Canada, founded in 2008, that focuses on seed and startup investments primarily in innovative companies across various sectors, including clean technologies, healthcare, manufacturing, retail, and information technology. With a network of over 230 angel investors, Anges Québec has invested more than $80 million in over 210 projects, supporting more than 115 businesses in Quebec. The firm aims to facilitate connections between angel investors and entrepreneurs in need of funding, with individual investments typically ranging from $25,000 to $100,000, and group investments between $250,000 and $1,000,000 per project. Additionally, Anges Québec offers a professional development center to enhance the skills and knowledge of its members, fostering a robust startup ecosystem in Canada.

Marc-Antoine Cantin

Angel investor

Marcel Larochelle

Angel Investor

Mark Paulin

Angel investor

Stéphane Pilette

Vice President

Past deals in Ottawa

Trexity

Seed Round in 2022
Founded in Ottawa, Ontario in 2019, Trexity is a shipping platform empowering customers with real-time tracking and on-demand delivery solutions. It connects users directly with drivers via its unique marketplace, enabling same-day shipments and last-mile logistics.

Spiderwort

Series A in 2022
Spiderwort is an innovative company based in Ottawa, Ontario, founded in 2015, focused on developing biomaterials for regenerative medicine. The company specializes in creating cellulose-based biomaterials that serve as living scaffolds, which can be utilized for various medical applications, including spinal cord injury repair and soft tissue regeneration. Spiderwort's products encompass a range of biological and synthetic polymers available in multiple forms, such as powders, gels, membranes, and pastes. Currently in the pre-clinical stage, their novel biomaterials have shown promising results in terms of biocompatibility and the ability to induce angiogenesis, which is the generation of blood vessels within the scaffold. This approach aims to advance the repair and regeneration of tissues within the human body, providing new solutions for challenging medical conditions.

Spiderwort

Seed Round in 2020
Spiderwort is an innovative company based in Ottawa, Ontario, founded in 2015, focused on developing biomaterials for regenerative medicine. The company specializes in creating cellulose-based biomaterials that serve as living scaffolds, which can be utilized for various medical applications, including spinal cord injury repair and soft tissue regeneration. Spiderwort's products encompass a range of biological and synthetic polymers available in multiple forms, such as powders, gels, membranes, and pastes. Currently in the pre-clinical stage, their novel biomaterials have shown promising results in terms of biocompatibility and the ability to induce angiogenesis, which is the generation of blood vessels within the scaffold. This approach aims to advance the repair and regeneration of tissues within the human body, providing new solutions for challenging medical conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.